Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2015-04-30 | Dr. Denner has significant experience overseeing the operations and research and development of healthcare companies and evaluating corporate governance matters. He also has extensive experience as an investor, particularly with respect to healthcare companies, and possesses broad healthcare industry knowledge. |
| Filing Date | Source Excerpt |
|---|---|
| 2009-04-13 | Alexander J. Denner, Ph.D., serves as Managing Director of entities affiliated with Carl C. Icahn... Dr. Denner has served in this position since August 2006... The Board of Directors recommends a vote FOR Dr. Denner as Class I Director (Proposal No. 1). |
| 2010-06-10 | Alexander J. Denner, Ph.D. has served as a director since May 2009 and Chairman of the Company’s Board of Directors since July 2009. The Compensation Committee currently consists of Mr. Classon (Chairman), Dr. Denner and Messrs. Levy and Micati. The Executive Committee consists of Dr. Denner (Chairman), Professor Mulligan and Mr. Classon. |
| 2011-04-08 | Alexander J. Denner, Ph.D. has served as a director since May 2009 and Chairman of the Company 27s Board of Directors since July 2009. Dr. Denner serves as Managing Director of entities affiliated with Carl C. Icahn...Dr. Denner brings to the Board extensive experience...The Board has nominated and recommends that the stockholders elect Alexander J. Denner...Chairman of the Board...Age 41...Total Director Compensation 363,025. |
| 2012-04-06 | Alexander J. Denner has served as a director since May 2009 and Chairman of the Company 27s Board of Directors since July 2009. Dr. Denner served as Managing Director of entities affiliated with Carl C. Icahn...Dr. Denner brings to the Board extensive experience...DIRECTOR COMPENSATION FOR FISCAL YEAR ENDED DECEMBER 31, 2011: Alexander J. Denner Fees Earned or Paid in Cash ($) 78,563, Stock Awards ($) 150,002, Option Awards ($) 150,002, Total ($) 378,568. |
| 2013-10-11 | Alexander J. Denner, Richard C. Mulligan, Thomas F. Deuel, George W. Hebard III and Richard A. Young, who are currently members of the Board, will not stand for re-election at the 2013 Annual Meeting. ... Dr. Denner presided at these executive sessions. ... The Governance and Nominating Committee currently consists of Professor Mulligan (Chairman) and Dr. Denner. |
Data sourced from SEC filings. Last updated: 2025-08-30